UNSPSC 41131729: Sickle cell test

In this classification a sickle cell test is a device used to determine the sickle cell hemoglobin content of human blood to detect sickle cell trait or sickle cell diseases US FDA regulates Sickle cell test under 21 CFR 864.7825 and under FDA product code GHM.

UNSPSC 41131729 Sickle cell test is a Commodity code covering clinical laboratory diagnostic testing and related screening services. State and local solicitations under this code do not reflect testing exclusively for sickle cell disease; rather, they encompass a broader range of drug screening, confirmation, and specialized clinical assays used in offender supervision, employment physicals, forensic analysis, and psychiatric patient monitoring. The kinds of work actually being solicited include urinalysis and immunoassay drug panels with LC/MS/MS or GC/MS confirmation (covering amphetamines, barbiturates, benzodiazepines, opiates, cocaine, fentanyl, and cannabinoids), breath alcohol testing equipment acquisition, certified reference materials (drug standards) for method validation in forensic laboratories, clozapine assay kits for psychiatric monitoring, pre-employment and fitness-for-duty physicals coupled with drug testing, and onsite specimen collection and laboratory result reporting. Issuing bodies include county community supervision and corrections departments, county human resources and medical functions, county forensic laboratories (often state-partnered), city college systems, state departments of public safety, and state healthcare operations. The code sees activity across Florida, Texas, Oregon, and Nevada, with Florida and Texas accounting for the largest recent concentration of opportunities.

Recent representative opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services at an estimated contract value of $600,000 over two years with three optional one-year renewals, encompassing approximately 25,031 annual tests with five-panel and six-panel immunoassay screening and LC/MS/MS confirmation; Benton County, Oregon's RFP (due July 7, 2026) for urinalysis testing services supporting the Family Treatment Court Program, requiring CLIA certification and confirmatory testing for all positive results with results delivered within 48 to 72 hours; Pinellas County, Florida's Invitation to Quote #26-0305-ITQ (due April 23, 2026) for 131 line items of certified reference materials and drug standards for forensic laboratory method validation and evidentiary sample analysis, funded through the Paul Coverdell Forensic Sciences Improvement Act with $72,126.85 in federal funds; and City Colleges of Chicago's RFP #MWJ2603 (due March 30, 2026) for employment screening services covering pre-employment drug testing and post-employment fitness-for-duty services for approximately 1,500 to 1,600 candidates annually across a seven-college system, with MBE participation goals of 25% and WBE participation goals of 7%.